Geneva Partners, LLC Johnson & Johnson Transaction History

Geneva Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	SELL	$151.05 - $180.26 $25,678 - $30,644	-170 Reduced 4.42%	3,674 $569,000
Q4 2022 Jan 23, 2023	SELL	$160.2 - $179.79 $4,004 - $4,494	-25 Reduced 0.65%	3,844 $0
Q3 2022 Oct 31, 2022	SELL	$161.33 - $179.52 $48,399 - $53,856	-300 Reduced 7.2%	3,869 $632,000
Q2 2022 Jul 25, 2022	BUY	$168.19 - $186.01 $26,069 - $28,831	155 Added 3.86%	4,169 $740,000
Q1 2022 May 03, 2022	SELL	$158.14 - $179.59 $824,700 - $936,561	-5,215 Reduced 56.51%	4,014 $711,000
Q4 2021 Jan 31, 2022	BUY	$155.93 - $173.01 $425,688 - $472,317	2,730 Added 42.01%	9,229 $1.58 Million
Q3 2021 Oct 18, 2021	BUY	$161.5 - $179.47 $229,491 - $255,026	1,421 Added 27.98%	6,499 $1.05 Million
Q2 2021 Aug 06, 2021	BUY	$159.48 - $171.07 $809,839 - $868,693	5,078 New	5,078 $837,000
Q3 2020 Oct 28, 2020	SELL	$140.38 - $153.83 $463,254 - $507,639	-3,300 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$128.81 - $155.51 $425,073 - $513,182	3,300 New	3,300 $464,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.